11-14 May 2011 Congress Dates...
Feb 25th, 2011 Deadline for early registration and accommodation...
Nov 1st, 2010 - Feb 21st, 2011 Deadline for online abstract submission...
 

May 12, 2011, Thursday

TIME MEETING HALL A MEETING HALL B
08:30-10:00 Multipl Myeloma
Scientific Chairs: Bart Barlogie (University of Arkansas, Myeloma Institute for Research and Therapy, USA)
                                Yıldız Aydın ( İstanbul University, İstanbul, Turkey)
Speakers:
kan_damlasi Genomics in Myeloma : Bart Barlogie (University of Arkansas, Myeloma Institute for Research and Therapy, USA)     
kan_damlasi High Risk Myeloma – The Challenge for the Future : Jean-Luc Harousseau (University of Nantes, France)
kan_damlasi The Curability of Myeloma:  Bart Barlogie (University of Arkansas, Myeloma Institute for Research and Therapy, USA)
  
10:00 - 10:30 COFFEE BREAK  
10:30 - 12:00 Acute Myeloid Leukemia
Scientific Chairs: Martin Tallman  (Memorial Sloan-Kettering Cancer Center, New York , USA)
                                Zafer Gülbaş (Anadolu Health Center, John Hopkins Hospital, Kocaeli, Turkey)
Speakers:
kan_damlasi Genetic Heterogeneity of AML: Making Sense of it All: Ross L. Levine (Memorial Sloan-Kettering Cancer Center, New York , USA)
kan_damlasi Novel Transplant Strategies in AML :   Jacob M. Rowe (  RAMBAM Health Care Campus,Israel)
kan_damlasi Crossing the “Great Divide” in AML in the Genomic Era : Martin Tallman  (Memorial Sloan-Kettering Cancer Center, New York , USA)   		  
12:00 - 14:00 LUNCH  
 
NOVARTIS SATELLITE SEMPOSIUM New Insights in CML
Scientific Chair: İbrahim Haznedaroğlu (Hacettepe University)
Speakers :
kan_damlasi Significance of Molecular Response in CML: Martin Mueller (Mannheim - Germany)
kan_damlasi Continuing Superiority of Nilotinib in CML: Richard Clark (Liverpool - UK)		 novartis
14:00 - 15:30 Diffuse Large B-Cell Lymphoma
Scientific Chairs: Craig Moskowitz (Memorial Sloan-Kettering Cancer Center, New York , USA)
                                Muhit Özcan (Ankara University, Ankara, Turkey) 
Speakers:
kan_damlasi An update on relapsed DLBCL: Christian Gisselbrecht (Hôpital Saint Louis,Paris,France)
kan_damlasi An update on interim FDG-PET scanning in DLBCL: Michel Meignan (Hôpital Henri Mondor, Université Paris Est Créteil)
kan_damlasi An update on untreated DLBCL: Craig Moskowitz (Memorial Sloan-Kettering Cancer Center, New York , USA)		  
15:30 - 16:00 COFFEE BREAK  
16:00 - 17:30 Chronic Myeloproliferative Disorders
Scientific Chairs: Ayalew Tefferi (Mayo Clinic, Mayo Graduate School of Medicine, Minnesota, USA)
                                Levent Ündar (Akdeniz University, Antalya, Turkey)
Speakers:
kan_damlasi New information on pathogenetic mechanisms in myeloproliferative neoplasms : Ross L. Levine (Memorial Sloan-Kettering, New York , USA)
kan_damlasi Diagnosis and management of BCR-ABL-negative myeloproliferative neoplasms: Ayalew Tefferi (Mayo Clinic, Mayo Graduate School of Medicine, Minnesota, USA)
kan_damlasi Diagnosis and management of eosinophilic and mast cell neoplasms : Ayalew Tefferi (Mayo Clinic, Mayo Graduate School of Medicine, Division of Hematology. Mayo Clinic, Minnesota, USA) 		  
18:00 - 19:00   OPENING CEREMONY